News

Previously, the National Institute for Health and Clinical Excellence (NICE) has refused to approve the kidney cancer drugs as they cost more than $70,000 a year per patient.

Prior to joining The Medicines Company, Mr Kelley held several senior management positions at Aventis Pharmaceuticals, most recently as senior vice president of global marketing and medical, where

According to the news source, the new pharmaceuticals factory will initially manufacture solubles which will be later sent to Egypt for quality assessment. The news source has quoted

The candidate vaccine is based on Vical’s DNA gene delivery technology and encodes human telomerase reverse transcriptase (hTERT). hTERT is the subject of separate licensing agreement. Vijay Samant,

Mr Walsh will contribute to the development of the company’s overall business strategy and oversee finance, legal, business development and general business operations. He has spent more than

Michael McCormick, the previous CEO has resigned to pursue other interests, the company said. Most recently, Mr Lunsford served as senior vice president and president of US commercial

According to the company, its restructuring program was designed to significantly reduce costs, centralize core operations, and refocus its business strategy in specific areas where the company’s products

Mr McCaulley will have responsibility for the company’s activities in the reconstructive devices market, including global marketing and sales in the Americas. He will report to David Dvorak,

Mentor will operate as a stand-alone business unit reporting through Ethicon, a Johnson & Johnson company and provider of suture, mesh and other products for a wide range